Isabelle Nanni

1.4k total citations
32 papers, 996 citations indexed

About

Isabelle Nanni is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Isabelle Nanni has authored 32 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 13 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Isabelle Nanni's work include Glioma Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Isabelle Nanni is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Cancer Genomics and Diagnostics (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Isabelle Nanni collaborates with scholars based in France, Switzerland and Slovenia. Isabelle Nanni's co-authors include L’Houcine Ouafik, Fréderic Fina, Dominique Figarella‐Branger, Olivier Chinot, Philippe Métellus, Pierre‐Emmanuel Morange, Marie‐Christine Alessi, Laurence Tiret, H. Aubert and Mireille Henry and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Isabelle Nanni

30 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Nanni France 17 362 310 303 245 206 32 996
Gerald Webersinke Austria 17 211 0.6× 353 1.1× 200 0.7× 236 1.0× 209 1.0× 54 964
Lynley V. Marshall United Kingdom 17 439 1.2× 459 1.5× 164 0.5× 292 1.2× 207 1.0× 62 1.2k
Bernardo Garicochea Brazil 19 381 1.1× 410 1.3× 195 0.6× 287 1.2× 210 1.0× 67 1.4k
Thomas Melchardt Austria 23 559 1.5× 380 1.2× 226 0.7× 486 2.0× 160 0.8× 93 1.4k
Davide Nicoli Italy 23 228 0.6× 377 1.2× 444 1.5× 200 0.8× 139 0.7× 72 1.4k
Guillaume Bataillon France 13 320 0.9× 222 0.7× 135 0.4× 74 0.3× 219 1.1× 42 1000
Fable Zustovich Italy 18 317 0.9× 298 1.0× 528 1.7× 207 0.8× 214 1.0× 87 949
Rüediger Liersch Germany 18 332 0.9× 438 1.4× 145 0.5× 84 0.3× 216 1.0× 33 942
Gaspar Reynés Spain 14 222 0.6× 371 1.2× 219 0.7× 472 1.9× 232 1.1× 40 898
Ann M. Lowe United States 9 253 0.7× 414 1.3× 174 0.6× 579 2.4× 273 1.3× 11 1.4k

Countries citing papers authored by Isabelle Nanni

Since Specialization
Citations

This map shows the geographic impact of Isabelle Nanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Nanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Nanni more than expected).

Fields of papers citing papers by Isabelle Nanni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Nanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Nanni. The network helps show where Isabelle Nanni may publish in the future.

Co-authorship network of co-authors of Isabelle Nanni

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Nanni. A scholar is included among the top collaborators of Isabelle Nanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Nanni. Isabelle Nanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campello, Chantal, Maryline Barrié, Thomas Graillon, et al.. (2023). Radio-chemotherapy feasibility for biopsy-only unresectable IDH wild-type glioblastomas (BO-GBM). Neuro-Oncology Practice. 10(6). 536–543. 1 indexed citations
2.
Frankel, Diane, Isabelle Nanni, L’Houcine Ouafik, et al.. (2023). Cytological Samples: An Asset for the Diagnosis and Therapeutic Management of Patients with Lung Cancer. Cells. 12(5). 754–754.
3.
Gaudy‐Marqueste, Caroline, Isabelle Nanni, Nathalie Beaufils, et al.. (2022). Adrenomedullin Secreted by Melanoma Cells Promotes Melanoma Tumor Growth through Angiogenesis and Lymphangiogenesis. Cancers. 14(23). 5909–5909. 8 indexed citations
4.
Beaufils, Nathalie, et al.. (2021). Machine learning random forest for predicting oncosomatic variant NGS analysis. Scientific Reports. 11(1). 21820–21820. 42 indexed citations
5.
Baldacci, Simon, Martin Figeac, Martine Antoine, et al.. (2019). High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study. Journal of Thoracic Oncology. 15(1). 120–124. 16 indexed citations
6.
Jeanson, A., Pascale Tomasini, M. Souquet-Bressand, et al.. (2019). Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 14(6). 1095–1101. 171 indexed citations
7.
Tabouret, Émeline, Emilie Denicolaï, Christine Delfino, et al.. (2016). Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma. Journal of Neuro-Oncology. 130(3). 431–437. 10 indexed citations
8.
Tabouret, Émeline, Emilie Denicolaï, Maryline Barrié, et al.. (2015). BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma. European Journal of Surgical Oncology. 41(12). 1685–1690. 28 indexed citations
9.
Tabouret, Émeline, Aurélie Tchoghandjian, Emilie Denicolaï, et al.. (2015). Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway. Oncotarget. 6(13). 11664–11675. 45 indexed citations
10.
Beau‐Faller, Michèle, Nathalie Prim, Anne-Marie Ruppert, et al.. (2012). Rare epidermal growth factor receptor (EGFR) mutations in 10,117 patients with non-small cell lung cancer (NSCLC) evaluated by the French ERMETIC IFCT network: Clinical, molecular, and survival data.. Journal of Clinical Oncology. 30(15_suppl). 10507–10507. 5 indexed citations
11.
Dahan, Laëtitia, Emmanuelle Norguet, Marie-Christine Étienne-Grimaldi, et al.. (2011). Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer. BMC Cancer. 11(1). 496–496. 40 indexed citations
12.
Coulibaly, Béma, Isabelle Nanni, Benoît Quilichini, et al.. (2010). Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression. Human Pathology. 41(6). 815–823. 17 indexed citations
13.
Colin, Carole, Brigitte Voutsinos‐Porche, Isabelle Nanni, et al.. (2009). High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas. Acta Neuropathologica. 118(6). 745–754. 56 indexed citations
14.
Lah, Tamara T., Isabelle Nanni, Christophe Dussert, et al.. (2009). Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors. Journal of neurosurgery. 112(5). 940–950. 21 indexed citations
15.
Métellus, P., Guillaume Dutertre, Choukri Mekkaoui, et al.. (2008). Intérêt de la mesure du volume sanguin régional cérébral relatif par IRM de perfusion dans la prise en charge des gliomes. Neurochirurgie. 54(4). 503–511. 4 indexed citations
16.
Nanni, Isabelle, Christophe Dussert, S. Fuentès, et al.. (2008). Implications pronostiques de différents marqueurs biologiques dans les méningiomes intracrâniens : à propos de 120 cas. Neurochirurgie. 54(6). 750–756. 7 indexed citations
17.
Lamy, Pierre‐Jean, Isabelle Nanni, Fréderic Fina, et al.. (2006). Reliability and Discriminant Validity of HER2 Gene Quantification and Chromosome 17 Aneusomy Analysis by Real-Time PCR in Primary Breast Cancer. The International Journal of Biological Markers. 21(1). 20–29. 17 indexed citations
18.
Figarella‐Branger, Dominique, Carole Colin, Olivier Chinot, et al.. (2006). Tumorothèque de l'AP-HM : cartographie moléculaire des gliomes. médecine/sciences. 22. 54–59. 3 indexed citations
19.
Régis, Jean, Xavier Muracciole, S. Fuentès, et al.. (2005). Evaluation of Fractionated Radiotherapy and Gamma Knife Radiosurgery in Cavernous Sinus Meningiomas: Treatment Strategy. Neurosurgery. 57(5). 873–886. 88 indexed citations
20.
Colin, Carole, Nathalie Baeza, Catherine Bartoli, et al.. (2005). Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization. Oncogene. 25(19). 2818–2826. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald Webersinke Breakdown of academic impact, for papers by Lynley V. Marshall Breakdown of academic impact, for papers by Bernardo Garicochea Breakdown of academic impact, for papers by Thomas Melchardt Breakdown of academic impact, for papers by Davide Nicoli Breakdown of academic impact, for papers by Guillaume Bataillon Breakdown of academic impact, for papers by Fable Zustovich Breakdown of academic impact, for papers by Rüediger Liersch Breakdown of academic impact, for papers by Gaspar Reynés Breakdown of academic impact, for papers by Ann M. Lowe
Rankless by CCL
2026